3Judith ME,Nancy C,Dolan PC.Update in women's health[J].Ann Intern Med,2000,133(6):808-814.
4Rosentha A,Jacobs I.Ovarian cancer screening[J].Semin Oncol,1998,25(3):315-325.
5Schraml P,Schwerdtfeger G,Burkhalter F,et al.Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma[J].Am J Pathol,2003,163(3):985-992.
6Zaharieva BM,Simon R,Diener PA,et al.High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1,FGF3,FGF4,EMS1) in urinary bladder cancer[J].J Pathol,2003,201(4):603-608.
7Fu M,Wang C,Li Z,et al.Cyclin D1:normal and abnormal functions[J].Endocrinology,2004,145(12):5439-5447
8Katoh M.WNT and FGF gene clusters (review)[J].Int J Oncol,2002,21(6):1269-1273
9Galdemard C,Brison O,Lavialle C.The proto-oncogene FGF-3 is constitutively expressed in tumorigenic,but not in non-tumorigenic,clones of a human colon carcinoma cell line[J].Oncogene,1995,10(12):2331-2342.
10Li JJ,Friedman-Kien AE,Cockerell C,et al.Evaluation of the tumorigenic and angiogenic potential of human fibroblast growth factor FGF3 in nude mice[J].J Cancer Res Clin Oncol,1998,124(5):259-264.
